JACOBS LEVY EQUITY MANAGEMENT, INC Q2 2021 Filing

Filed August 16, 2021

Portfolio Value

$14.8B

Holdings

1,017

Report Date

Q2 2021

Filing Type

13F-HR

All Holdings (1,017 positions)

#StockSharesValue% PortfolioType
1001
VRAVERA BRADLEY INC
12,395$154.0M1.04%
1002
PCTEL INC
23,272$152.0M1.03%
1003
CFBCROSSFIRST BANKSHARES INC
10,759$148.0M1.00%
1004
FULCFULCRUM THERAPEUTICS INC
13,789$145.0M0.98%
1005
LBCUSDLUTHER BURBANK CORP
12,109$144.0M0.98%
1006
ALTGALTA EQUIPMENT GROUP INC
10,143$135.0M0.92%
1007
AMERICAN FIN TR INC
15,119$128.0M0.87%
1008
DECIBEL THERAPEUTICS INC
13,594$117.0M0.79%
1009
CRD/BCRAWFORD & CO
13,330$115.0M0.78%
1010
IMARA INC
13,794$109.0M0.74%
1011
MANITEX INTL INC
14,300$104.0M0.71%
1012
FORTRESS BIOTECH INC
24,609$88.0M0.60%
1013
LPTXEURLEAP THERAPEUTICS INC
51,714$85.0M0.58%
1014
PGENPRECIGEN INC
11,359$74.0M0.50%
1015
PXLWEURPIXELWORKS INC
19,075$65.0M0.44%
1016
METACRINE INC
14,284$54.0M0.37%
1017
SURGALIGN HOLDINGS INC
16,710$23.0M0.16%
PreviousPage 11 of 11